News for FibroGen, Inc. (0IL8.L)

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. ( FGEN) will announce fourth quarter and full year 2024 financial results on Monday, March 17

**media[556123]**

Sale of FibroGen China: Announced sale to AstraZeneca for approximately $160 million, enhancing financial stability.Enterprise Value: Transaction includes an e

**media[511571]**

- Srinivas Rao M.D., Ph.D. succeeds as sole Chief Executive Officer- Kevin Craig, M.D. promoted to Chief Medical Officer- Glenn Short, Ph.D. promoted to Chief S

FibroGen, Inc. (NASDAQ:FGEN) Q3 2024 Earnings Conference Call November 12, 2024 5:00 PM ETCompany ParticipantsDavid DeLucia - VP, Corporate FP&A &...

Revenue: Total revenue for Q3 2024 was $46.3 million, marking a 15% increase year-over-year, driven by strong performance in China.Net Loss: Reported a net los

FibroGen to Report Third Quarter 2024 Financial Results

Total Revenue: $50.6 million for Q2 2024, a 14% increase year-over-year.Roxadustat Net Product Revenue in China: $49.6 million for Q2 2024, a 108% increase yea

Aug 06, 2024 / 09:00PM GMTOperator Good day and welcome to the FibroGen second quarter 2024 earnings conference call. (Operator Instructions) Please note this e

The increase in emerging industries and the increasing investment in developing advanced technologies are opportunities for liver fibrosis market growth....

FibroGen, Inc. (NASDAQ:NASDAQ:FGEN) Q2 2024 Earnings Conference Call August 6, 2024 5:00 PM ETCompany ParticipantsDavid DeLucia - CFA Vice President,...

FibroGen to cut 75% of U.S. workforce amid restructuring

WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and...

China-based MicroAlgo Inc. (MLGO) is up over 157 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Loading... Loading... Shares of Healthequity Inc HQY rose sharply in today's pre-market trading as the company reported better-than-expected first-quarter fina...

Loading... Loading... Shares of Beyond, Inc. BYON fell sharply during Tuesday’s session following weaker-than-expected quarterly results. Beyond posted adju...

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook. Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday.

SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Deyaa Adib, M.D., an executive leader...